Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

SCHIZOCHYTRIUM AGGREGATUM OIL.

Insufficient Data / SKIN CONDITIONING - EMOLLIENT

Schizochytrium aggregatum oil is a potent source of docosahexaenoic acid (DHA), a key omega-3 fatty acid. This botanical oil is recognized for its multifaceted benefits, including anti-inflammatory properties, robust support for the skin barrier, and significant antioxidant activity, contributing to overall skin resilience.

Anti-inflammatory Skin Barrier Support Antioxidant Moisturizing Anti-aging Hair Follicle Health

Science

This marine-derived oil delivers docosahexaenoic acid (DHA), an essential omega-3 fatty acid, directly to the skin. Its primary mechanism involves modulating inflammatory responses, thereby reducing irritation and redness. It actively contributes to strengthening the skin's natural barrier, optimizing hydration and protection. Furthermore, it acts as an antioxidant, neutralizing free radicals. Preliminary in vitro and animal research suggests it can enhance intrinsic antioxidation pathways and inhibit ferroptosis in dermal papilla cells, indicating potential for cellular protection and regeneration.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

The Formula

Solubility
Oil
Optimal pH N/A
0 7 14

Stability

Given its high concentration of beneficial unsaturated omega-3 fatty acids, Schizochytrium aggregatum oil is prone to oxidative degradation. To maintain its integrity and efficacy within formulations, co-formulation with robust antioxidants is essential.

Synergies

  • Tocopherols (alpha, beta, gamma, delta)
  • 1-o-galloylglycerol

Safety

CIR Status
Not reviewed
Sensitization risk Unknown

While Schizochytrium aggregatum oil has not undergone specific Cosmetic Ingredient Review (CIR) or Scientific Committee on Consumer Safety (SCCS) assessments for cosmetic applications, related strains of Schizochytrium sp. oil, which also contain DHA, have been granted Generally Recognized As Safe (GRAS) status by the FDA for various food uses, including infant formulas at concentrations up to 0.5% w/w of total fat as DHA. Oral animal studies indicate a no observable adverse effect level (NOAEL) up to 5% by weight in the diet for rats, equating to approximately 3250-4260 mg/kg bw/day. This suggests a high tolerance, translating to an estimated human equivalent oral dose of around 30g/day for a 60kg adult. However, it is important to note that an EFSA opinion on a specific strain (ATCC-20889) for novel food use highlighted insufficient species-level characterization and specific toxicology data for that particular strain, emphasizing that such conclusions pertain to specific strains and food applications rather than topical cosmetic use broadly.


Your Skin

Yes Normal
Yes Dry
Yes Oily
Yes Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Insufficient Data

Schizochytrium aggregatum oil presents significant potential for skin health, offering anti-inflammatory, barrier-supporting, and antioxidant benefits, yet further specific human topical clinical research is needed to fully establish its efficacy and optimal usage.


Related

Finding similar ingredients…